Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Textual)

v3.7.0.1
Commitments and Contingencies (Details Textual) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Commitments And Contingencies [Line Items]      
Royalty Expense $ 185,000 $ 217,000  
Accrued Liabilities, Current 4,672,000   $ 5,286,000
Payments to Acquire Businesses, Gross 675,000 2,573,000  
Revenues $ 4,594,000 3,957,000  
Installment One [Member]      
Commitments And Contingencies [Line Items]      
Business Combination Agreed Contingent Consideration Payable Ratio In Excess Of Certain Revenue Targets 3.5    
Installment One [Member] | Two Thousand Fifteen MIST Therapy [Member]      
Commitments And Contingencies [Line Items]      
Revenues   10,200,000  
Installment One [Member] | Two Thousand Fourteen MIST Therapy [Member]      
Commitments And Contingencies [Line Items]      
Revenues   8,700,000  
Installment two [Member]      
Commitments And Contingencies [Line Items]      
Business Combination Agreed Contingent Consideration Payable Ratio In Excess Of Certain Revenue Targets 3.5    
Payments to Acquire Businesses, Gross $ 675,000    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares 1    
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned $ 675,000    
Installment two [Member] | Two Thousand Fifteen MIST Therapy [Member]      
Commitments And Contingencies [Line Items]      
Revenues 10,200,000    
Installment two [Member] | Two Thousand Sixteen MIST Therapy [Member]      
Commitments And Contingencies [Line Items]      
Revenues 10,500,000    
Human Longevity, Inc [Member]      
Commitments And Contingencies [Line Items]      
Royalty Expense 185,000 67,000  
Accrued Liabilities, Current 185,000    
Revenue Recognition, Milestone Method, Milestone Expenses 1,000,000    
Human Longevity, Inc [Member] | First Commercial Sale [Member]      
Commitments And Contingencies [Line Items]      
Contractual Obligation, Due in Next Twelve Months 500,000    
Human Longevity, Inc [Member] | Second Commercial Sale [Member]      
Commitments And Contingencies [Line Items]      
Contractual Obligation, Due in Next Twelve Months 500,000    
Choice Therapeutics, Inc. [Member]      
Commitments And Contingencies [Line Items]      
Business Combination, Contingent Consideration, Liability $ 500,000    
Contingent Consideration [Member] | Installment One [Member]      
Commitments And Contingencies [Line Items]      
Payments to Acquire Businesses, Gross   $ 2,600,000  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares   986,000  
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned   $ 2,600,000